Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 8, 2019
[ Thu, Aug 08th 2019
] - WOPRAI
[ Thu, Aug 08th 2019
] - WOPRAI
[ Thu, Aug 08th 2019
] - WOPRAI
[ Thu, Aug 08th 2019
] - WOPRAI
[ Thu, Aug 08th 2019
] - WOPRAI
[ Thu, Aug 08th 2019
] - WOPRAI
Wed, August 7, 2019
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
Tue, August 6, 2019
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
Ed Arce Maintained (AKBA) at Strong Buy with Decreased Target to $17 on, Aug 6th, 2019
Ed Arce of HC Wainwright & Co., Maintained "Akebia Therapeutics, Inc." (AKBA) at Strong Buy with Decreased Target from $19 to $17 on, Aug 6th, 2019.
Ed has made no other calls on AKBA in the last 4 months.
There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Ed's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ed
- Eric Joseph of "JP Morgan" Initiated at Buy on, Thursday, May 2nd, 2019
Similar Stocks and Investing Articles
[ Wed, May 29th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Mon, Jan 14th 2019
] - WOPRAI
[ Thu, Oct 11th 2018
] - WOPRAI
[ Wed, Jun 06th 2018
] - WOPRAI
[ Wed, Jun 06th 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Fri, Oct 06th 2017
] - WOPRAI
[ Thu, Aug 16th 2012
] - WOPRAI